Literature DB >> 27810501

Novel tuberculosis susceptibility candidate genes revealed by the reconstruction and analysis of associative networks.

Elena Yu Bragina1, Evgeny S Tiys2, Alexey A Rudko3, Vladimir A Ivanisenko4, Maxim B Freidin3.   

Abstract

Tuberculosis (TB) is a common infectious disease caused by M. tuberculosis. The risk of the disease is dependent on complex interactions between host genetics and environmental factors. Accumulated genomic data, along with novel methodological approaches such as associative networks, facilitate studies into the inherited basis of TB. In the current study, we carried out the reconstruction and analysis of an associative network representing molecular interactions between proteins and genes associated with TB. The network predominantly comprises of well-studied key proteins and genes which are able to govern the immune response against M. tuberculosis. However, this approach also allowed us to reveal 12 proteins encoded by genes, the polymorphisms of which have never been studied in relation to M. tuberculosis infection. These proteins include surface antigens (CD4, CD69, CD79, CD80, MUC16) and other important components of the immune response, inflammation, pathogen recognition, cell migration and activation (HCST, ADA, CP, SPP1, CXCR4, AGER, PACRG). Thus, the associative network approach enables the discovery of new candidate genes for TB susceptibility. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Associative network; Genes; Susceptibility; Tuberculosis

Mesh:

Year:  2016        PMID: 27810501     DOI: 10.1016/j.meegid.2016.10.030

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  8 in total

1.  Genome-wide association study identifies loci associated with milk leukocyte phenotypes following experimental challenge with Streptococcus uberis.

Authors:  Lydia Siebert; Margaret E Staton; Susan Headrick; Mark Lewis; Barbara Gillespie; Charles Young; Raul A Almeida; Stephen P Oliver; Gina M Pighetti
Journal:  Immunogenetics       Date:  2018-06-03       Impact factor: 2.846

2.  FunGeneNet: a web tool to estimate enrichment of functional interactions in experimental gene sets.

Authors:  Evgeny S Tiys; Timofey V Ivanisenko; Pavel S Demenkov; Vladimir A Ivanisenko
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

3.  Sequence variant analysis of RNA sequences in severe equine asthma.

Authors:  Laurence Tessier; Olivier Côté; Dorothee Bienzle
Journal:  PeerJ       Date:  2018-10-11       Impact factor: 2.984

4.  Impact of the Polymorphism of the PACRG and CD80 Genes on the Development of the Different Stages of Tuberculosis Infection.

Authors:  Elena Yu Bragina; Nadezhda P Babushkina; Anna F Garaeva; Alexey A Rudko; Dmitry Yu Tsitrikov; Densema E Gomboeva; Maxim B Freidin
Journal:  Iran J Med Sci       Date:  2019-05

5.  Genome-Wide Association Study in Mexican Holstein Cattle Reveals Novel Quantitative Trait Loci Regions and Confirms Mapped Loci for Resistance to Bovine Tuberculosis.

Authors:  Sara González-Ruiz; Maria G Strillacci; Marina Durán-Aguilar; Germinal J Cantó-Alarcón; Sara E Herrera-Rodríguez; Alessandro Bagnato; Luis F Guzmán; Feliciano Milián-Suazo; Sergio I Román-Ponce
Journal:  Animals (Basel)       Date:  2019-08-30       Impact factor: 2.752

6.  Clinical relevance of the lnc-HNF1B-3:1 genetic polymorphisms in Western Chinese tuberculosis patients.

Authors:  Qian Wu; Huiyu Zhong; Hao Bai; Tangyuheng Liu; Jiajia Song; Yang Wen; Xingbo Song; Binwu Ying
Journal:  J Clin Lab Anal       Date:  2019-11-06       Impact factor: 2.352

7.  Functional Expression, Purification and Identification of Interaction Partners of PACRG.

Authors:  Tiankai Liu; Haizhou Zhao; Shaofen Jian; Shu Gong; Sainan Li; Yanhong Ma; Jun Chen; Wenhua Liu
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

Review 8.  A Survey of Gene Prioritization Tools for Mendelian and Complex Human Diseases.

Authors:  Olga Zolotareva; Maren Kleine
Journal:  J Integr Bioinform       Date:  2019-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.